SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet ($STRK) is trending as its ecosystem displays robust growth with record TVL and stablecoin supply, sparking discussion around its ZK-STARKs technology providing quantum resistance and privacy features for institutional adoption. The community remains convicted in its long-term vision as critical infrastructure for Ethereum scaling and BTCFi, further solidified by its token's expansion to Solana.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce Holdings is trending as a key beneficiary of global rearmament and surging civil aerospace demand, highlighted by a significant engine order from Delta Air Lines and numerous defense contracts. The community anticipates strong upcoming earnings, fueled by these catalysts and long-term optimism for its small modular reactor (SMR) and power systems solutions for data centers.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending following its latest earnings report, which, despite beating revenue and EPS, saw future profit guidance trimmed and analyst price targets cut, triggering a sharp sell-off. The community is fiercely debating whether this decline is an overreaction driven by broader 'AI panic' and M&A integration costs, or a justified repricing for an overvalued stock with concerns over declining margins.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending due to heightened buyout speculation, driven by the community's frustration over perceived management silence regarding crucial AUR200 pipeline updates and ongoing patent developments. This fuels anticipation of a potential acquisition, as investors weigh strategic board connections against the company's established lupus nephritis drug and promising autoimmune assets.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is a focal point for investors anticipating the imminent BLA resubmission for its Duchenne Muscular Dystrophy therapy, Deramiocel, driven by robust Phase 3 data and increasing institutional ownership, alongside excitement for its promising exosome platform.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors vigorously debate NVIDIA's recent exit from its APLD stake, with some viewing it as strategic profit-taking for an AI infrastructure provider that has matured, while others interpret it as a concerning signal about its future prospects.

WorldFinancial

WLFI is highly contentious amid an anticipated Mar-a-Lago event with institutional players, where the community debates potential institutional adoption against ongoing congressional scrutiny and a probe into its foreign investment and governance.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony is actively discussed following its significant joint venture with Americas Gold and Silver to establish North America's first commercial-scale hydrometallurgical processing facility for critical minerals like antimony, copper, and silver. Despite widespread community excitement about this "game-changer" for domestic supply and increased institutional buying, many investors express frustration over what they perceive as aggressive market manipulation suppressing the stock.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera Inc. is trending with significant trading volume as its recent earnings call highlighted optimism for MST technology addressing critical power efficiency in AI chips and Gate-All-Around architectures, fueling widespread community discussion about potential commercial agreements with major foundries.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as a critical player in the evolving AI ecosystem, driven by its strategic partnership with Palantir, involvement in U.S. defense AI initiatives, and expansion into AI robotics. Amidst a broader market sell-off in AI, the community is debating whether the recent dip represents an exceptional buying opportunity, citing the company's strong fundamentals and vital role in training AI for various sectors, including emerging humanoid AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Has Celcuity (CELC) Outpaced Other Medical Stocks This Year?

Here is how Celcuity, Inc. (CELC) and Day One Biopharmaceuticals, Inc. (DAWN) have performed compared to their sector so far this year.

Soleus Adds a Significant Number of Celcuity Shares

Key PointsSoleus increased its Celcuity stake by 629,398 shares...

Celcuity CEO Sets July 17 PDUFA for Gedatolisib, Teases VIKTORIA-1 Mutant Data at Conference

Celcuity (NASDAQ:CELC) CEO Brian Sullivan outlined the company's expected regulatory timeline and commercial preparations for gedatolisib during an appearance at the Guggenheim Healthcare Conference...

Candriam S.C.A. Increases Holdings in Celcuity, Inc. $CELC

Candriam S.C.A. increased its position in Celcuity, Inc. (NASDAQ:CELC - Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities...

Celcuity, Inc. $CELC Stake Boosted by New York State Common Retirement Fund

New York State Common Retirement Fund raised its holdings in shares of Celcuity, Inc. (NASDAQ:CELC - Free Report) by 68.0% in the 3rd quarter, according to the company in its most recent disclosure...

Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump

Key PointsDavid Dalvey sold 20,000 shares indirectly on Jan. 27, 2026 for a transaction value of ~$2.4 million, at a weighted average price of $120.03 per share...

Atle Fund Management AB Takes $1.84 Million Position in Celcuity, Inc. $CELC

Atle Fund Management AB bought a new position in shares of Celcuity, Inc. (NASDAQ:CELC - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...

Celcuity (NASDAQ:CELC) Director David Dalvey Sells 20,000 Shares

Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director David Dalvey sold 20,000 shares of the company's stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of...

Celcuity (NASDAQ:CELC) Director Sells $2,400,600.00 in Stock

Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director David Dalvey sold 20,000 shares of the stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $120.03...

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?

Here is how Cabaletta Bio, Inc. (CABA) and Celcuity, Inc. (CELC) have performed compared to their sector so far this year.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

CELC
Celcuity Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CELC News

CELCCelcuity Inc